Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    "lamellar ichthyosis" OR "Congenital Ichthyosiform Erythrodermas" OR "Congenital Ichthyosiform Erythroderma"
Show Display Options
RSS Create an RSS feed from your search for:
"lamellar ichthyosis" OR "Congenital Ichthyosiform Erythrodermas" OR "Congenital Ichthyosiform Erythroderma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
Condition: Congenital Ichthyosis
Interventions: Drug: PAT-001, 0.1%;   Drug: PAT-001, 0.2%;   Drug: Vehicle
2 Unknown  Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Condition: Lamellar Ichthyosis
Intervention: Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side
3 Recruiting A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
Condition: Ichthyosis
Intervention: Other: Observation
4 Completed Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Condition: Ichthyosis, Lamellar
Intervention: Drug: Liarozole
5 Completed Study of Scaling Disorders and Other Inherited Skin Diseases
Conditions: Genetic Skin Disease;   Keratosis Follicularis;   Lamellar Ichthyosis
6 Completed Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
Condition: Ichthyosis
Intervention: Drug: monolaurin cream
7 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
8 Recruiting International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
Condition: Neutral Lipid Storage Disease
9 Recruiting Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
Conditions: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV);   Neutral Lipid Storage Disease With Myopathy (NLSD-M)
Intervention: Dietary Supplement: CNT-02
10 Recruiting Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Conditions: Metabolism, Inborn Errors;   Lipid Metabolism, Inborn Errors;   Carbohydrate Metabolism, Inborn Errors;   Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV);   Carnitine Palmitoyl Transferase 2 Deficiency;   VLCAD Deficiency;   Medium-chain Acyl-CoA Dehydrogenase Deficiency;   Multiple Acyl-CoA Dehydrogenase Deficiency;   Carnitine Transporter Deficiency;   Neutral Lipid Storage Disease;   Glycogen Storage Disease Type II;   Glycogen Storage Disease Type III;   Glycogen Storage Disease Type IV;   Glycogen Storage Disease Type V;   Muscle Phosphofructokinase Deficiency;   Phosphoglucomutase 1 Deficiency;   Phosphoglycerate Mutase Deficiency;   Phosphoglycerate Kinase Deficiency;   Phosphorylase Kinase Deficiency;   Beta Enolase Deficiency;   Lactate Dehydrogenase Deficiency;   Glycogen Synthase Deficiency
Intervention: Other: Sugar
11 Completed The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Intervention: Drug: Fibrate treatment
12 Completed A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Condition: Sjögren-Larsson Syndrome
Interventions: Drug: Active topical NS2 1% dermatologic cream;   Drug: Vehicle placebo 0.0% NS2 dermatologic cream
13 Active, not recruiting Clinical Trial Using Humira in Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Drug: Adalimumab
14 Recruiting Natural History and Biological Study of Netherton Syndrome
Conditions: Netherton Syndrome;   Healthy
Interventions: Other: Biopsy;   Other: Blood sample
15 Recruiting Gene Therapy for Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Genetic: One 20cm2/10cm2 autologous skin sheet graft
16 Completed A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
Conditions: Healthy Volunteers;   Atopic Dermatitis;   Netherton Syndrome
Interventions: Drug: BPR277 ointment (controlled application);   Drug: Placebo (Vehicle);   Drug: BPR277 ointment;   Drug: BPR277
17 Withdrawn Novel Treatment for Syndromic Ichthyoses
Conditions: Syndromic Ichthyoses;   CHILD Syndrome;   Smith Lemli Opitz Syndrome;   Conradi Syndrome
Intervention: Drug: Lovastatin
18 Completed
Has Results
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Conditions: Atopic Dermatitis;   Ichthyosis Vulgaris
Intervention: Genetic: Buccal Swab
19 Completed
Has Results
Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Drug: Pimecrolimus 1% Cream

Indicates status has not been verified in more than two years